Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02440464
Title Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Heart, Lung, and Blood Institute (NHLBI)
Indications

multiple myeloma

Therapies

Methotrexate + Tacrolimus

Ixazomib

Fludarabine + Melphalan

Bortezomib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama Birmingham Alabama 35294 United States Details
City of Hope National Medical Center Duarte California 91010 United States Details
H. Lee Moffitt Cancer Center Tampa Florida 33624 United States Details
Emory University Atlanta Georgia 30322 United States Details
BMT Northside Atlanta Georgia 30342 United States Details
Loyola University Medical Center Maywood Illinois 60153 United States Details
University of Kentucky Lexington Kentucky 40536 United States Details
University of Minnesota Minneapolis Minnesota 55455 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
Duke University Medical Center Durham North Carolina 27705 United States Details
Ohio State/Arthur G. James Cancer Hospital Columbus Ohio 43210 United States Details
University of Texas /MD Anderson CRC Houston Texas 77030 United States Details
West Virginia University Morgantown West Virginia 26506 United States Details
University of Wisconsin Hospital & Clinics Madison Wisconsin 53792 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53211 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field